Repositorio Dspace

Listar por tema "Immune Checkpoint Inhibitors/adverse effects"

Listar por tema "Immune Checkpoint Inhibitors/adverse effects"

Ordenar por:Orden:Resultados:

  • Efficacy and Safety of Dupilumab in Immune Checkpoint Inhibitor Induced Bullous Pemphigoid: A Spanish Multicentric Case Series 
    Tejero-García, Cecilia; Reig, Francesc-Alamon; Bosch-Amate, Xavier; Carrera, Cristina; Giavedoni, Priscila; Gil-Faure, Inmaculada; Jiménez-Antón, Alicia; Mayor-Ibarguren, Ander; Barcena, Teresa-Usero; Álvarez-Salafranca, Marcial; Gamissans-Canada, Marta; López-Robles, Joaquín; Martínez-Fernández, Sandra; Segura, Sonia; Sánchez-Aguilar-Rojas, Dolores; Florez, Ángeles (ACTA DERMATO-VENEREOLOGICA, 2026-05-21)
    Immune checkpoint inhibitors (ICIs) have signifi-cantly improved oncologiconcological outcomes. However, ICIs can elicit immune-mediated adverse effects that may require treatment discontinuation and potentially affect ...
  • Immune checkpoint inhibitors-associated thrombosis in patients with head and neck cancer: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group 
    Sánchez-Cánovas, Manuel; Moya-Hernández, Miguel-Ángel; Adoamnei, Evdochia; Cacho-Lavin, Diego; Fernández-Garay, David; Quintanar-Verduguez, Teresa; Rogado-Revuelta, Jacobo; García-Verdejo, Francisco-José; García-Adrián, Silvia; Ferrer-Pérez, Ana-Isabel; Guirao-García, María-Esperanza; López-Robles, Javier; Mendiola-Olivares, Jaime; Muñoz-Martín, Andrés-Jesús (SPRINGER INT PUBL AG, 2024-06-21)
    PURPOSE: Both venous and arterial thrombotic events (VTE/AT) can be associated with Immune Checkpoint Inhibitors (ICI). However, there is a paucity of information apropos patients in routine clinical practice. METHODS: ...